Clinical Trial Update: Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004% [Phase 4]

View source ↗

Summary

Phase 4 trial comparing diurnal intraocular pressure curves between bimatoprost 0.03% and travoprost 0.004% in glaucoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Bimatoprost (bimatoprost)
• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Innovative Medical | Conditions: Glaucoma | Phase 4 | Status: COMPLETED